- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.12.25 | Advanced Biomed Inc. - 8-K, Current Report | - | SEC Filings | ||
| 30.12.25 | Advanced Biomed-Aktie steigt nach Verkauf von Hongkong-Tochter | 1 | Investing.com Deutsch | ||
| 30.12.25 | Advanced Biomed veräußert Hongkong-Tochter für 23.000 US-Dollar | 1 | Investing.com Deutsch | ||
| 30.12.25 | Advanced Biomed sells Hong Kong subsidiary for $23,000 | 1 | Investing.com | ||
| ADVANCED BIOMED Aktie jetzt für 0€ handeln | |||||
| 30.12.25 | Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary | 224 | GlobeNewswire (Europe) | Tainan City, Taiwan, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the "Company", "Advanced Biomed"), a biotechnology company focused on developing and commercializing innovative... ► Artikel lesen | |
| 19.11.25 | Advanced Biomed Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 14.11.25 | Advanced Biomed Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 08.10.25 | Advanced Biomed Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 30.09.25 | Advanced Biomed Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
| 19.09.25 | Advanced Biomed Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 19.09.25 | Advanced Biomed Inc. Announces Launch of A+PerfusC - Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery | 1 | GlobeNewswire (USA) | ||
| 24.07.25 | Advanced Biomed Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 24.07.25 | Advanced Biomed registers 40M shares for potential $25M equity line | 1 | Seeking Alpha | ||
| 23.07.25 | Advanced Biomed Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 07.03.25 | Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering | 576 | GlobeNewswire (Europe) | Tainan, Taiwan, March 07, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (the "Company") (NASDAQ: ADVB), a biotechnology company focused on early screening and detection, diagnosis and staging, and... ► Artikel lesen | |
| 06.03.25 | Advanced Biomed Inc. Announces Pricing of Initial Public Offering | 420 | GlobeNewswire (Europe) | Tainan, Taiwan, March 06, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (the "Company" or "Advanced Biomed"), a biotechnology company focused on early screening and detection, diagnosis and staging... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 46,310 | +0,46 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,180 | -2,59 % | EILMELDUNG: Fresenius Medical Care-Aktie im freien Fall - Anleger fliehen aus dem Wert! | ||
| FRESENIUS | 48,970 | +1,09 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,510 | -2,85 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PROGYNY | 26,800 | +0,49 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,200 | -0,90 % | Citizens reiterates Market Outperform rating on Privia Health stock | ||
| PROCEPT BIOROBOTICS | 33,920 | -2,28 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GENEDX | 136,55 | +0,55 % | GeneDx to launch whole genome sequencing test for fetal anomalies | ||
| HEARTFLOW | 32,580 | +4,52 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 42,640 | +0,71 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| BETA BIONICS | 31,490 | +0,35 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,300 | +0,14 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| BILLIONTOONE | 89,44 | -5,78 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 8,870 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| GERRESHEIMER | 27,700 | -0,72 % | Gerresheimer Aktie: Einer der Rebound-Favoriten für 2026! | © Foto: Foto von Tima Miroshnichenko auf PexelsNach einem verheerenden Börsenjahr 2025 könnte die Gerresheimer-Aktie jetzt die große Überraschung werden.Der Pharmaverpackungs-Spezialist aus Düsseldorf... ► Artikel lesen |
ADVANCED BIOMED INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,001 (+0,31 %) liegt der Kurs bei 0,351 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ADVANCED BIOMED INC finden Sie auf Wallstreet Online.